ArticleBiophotonics discovery2026
Multimodal optical imaging strategy to evaluate the microscopic biodistribution of SERS gold nanoparticles across histology sections.
Article in Biophotonics discovery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Significance: Surface-enhanced Raman scattering (SERS) gold nanoparticles (AuNPs) are widely used for molecular imaging and diagnostics, but their non-biodegradable nature necessitates accurate, spatially resolved methods to assess long-term biodistribution. Existing approaches often lack sensitivity and spatial resolution or require destructive sample preparation. Aim: We evaluate multiphoton luminescence (MPL) microscopy as a label-free approach for detecting SERS AuNPs in biological tissues while using Raman imaging for spectroscopic validation of nanoparticle (NP) localization. Approach: SERS AuNPs were intravenously administered in mice at multiple doses and analyzed at 1- and 8-week time points using MPL and Raman microscopy. Quantitative analyses were used to compare NP signals across organs, doses, and time points. Results: MPL and Raman imaging both detected SERS AuNP-associated signals across all doses, with strong spatial correlation observed among modalities. Dose-dependent increases in signal were observed for both modalities, with normalized positive pixel area fraction in liver increasing from 0.02 at 0.1 nM to 0.99 at 5 nM. Whole-organ mapping revealed preferential accumulation in the liver and spleen, while longitudinal analysis demonstrated increased NP aggregation at later time points. Conclusions: MPL enables sensitive, label-free detection of SERS AuNPs and, when combined with Raman imaging, provides a non-destructive framework for spatially resolved biodistribution analysis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.